FdaApplication

NDA 021330

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHALEON US HOLDINGS LLC
application_typeNDA
approval_date2002-10-31

Products (2)

ProductActive ingredientStrengthDosage form
NICORETTENICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE;ORAL
NICORETTENICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE;ORAL

2 products